Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Macropinocytosis of Bevacizumab by Glioblastoma Cells in the Perivascular Niche Affects their Survival.

Müller-Greven G, Carlin CR, Burgett ME, Ahluwalia MS, Lauko A, Nowacki AS, Herting CJ, Qadan MA, Bredel M, Toms SA, Lathia JD, Hambardzumyan D, Sarkaria JN, Hamerlik P, Gladson CL.

Clin Cancer Res. 2017 Nov 15;23(22):7059-7071. doi: 10.1158/1078-0432.CCR-17-0249. Epub 2017 Sep 14.

PMID:
28912141
2.

Genetic driver mutations define the expression signature and microenvironmental composition of high-grade gliomas.

Herting CJ, Chen Z, Pitter KL, Szulzewsky F, Kaffes I, Kaluzova M, Park JC, Cimino PJ, Brennan C, Wang B, Hambardzumyan D.

Glia. 2017 Dec;65(12):1914-1926. doi: 10.1002/glia.23203. Epub 2017 Aug 24.

PMID:
28836293
3.

Cellular and Molecular Identity of Tumor-Associated Macrophages in Glioblastoma.

Chen Z, Feng X, Herting CJ, Garcia VA, Nie K, Pong WW, Rasmussen R, Dwivedi B, Seby S, Wolf SA, Gutmann DH, Hambardzumyan D.

Cancer Res. 2017 May 1;77(9):2266-2278. doi: 10.1158/0008-5472.CAN-16-2310. Epub 2017 Feb 24.

4.

Iridium(iii)-bis(imidazolinyl)phenyl catalysts for enantioselective C-H functionalization with ethyl diazoacetate.

Weldy NM, Schafer AG, Owens CP, Herting CJ, Varela-Alvarez A, Chen S, Niemeyer Z, Musaev DG, Sigman MS, Davies HML, Blakey SB.

Chem Sci. 2016 May 1;7(5):3142-3146. doi: 10.1039/c6sc00190d. Epub 2016 Feb 5.

Supplemental Content

Loading ...
Support Center